Aprea Therapeutics shareholders approve reverse stock split at ratio of 1:3 to 1:20

Proposal 2: Stockholders approved the adjournment of the Special Meeting to a later date or dates, if necessary or appropriate, to solicit additional proxies if there are insufficient votes to adopt the Reverse Stock Split Proposal. Votes For Votes Against Abstentions Broker Non-Votes 36,441,099 1,892,580 565,864 —

Proposal 1: Stockholders approved the amendments to the Company’s Certificate of Incorporation, to effect a reverse stock split at a ratio of 1-for-3 and 1-for-20, inclusive, with the exact ratio to be set within that range at the discretion of the Company’s Board of Directors before February 28, 2023 without further approval or authorization of our stockholders and with our Board of Directors able to elect to abandon such proposed amendment and not effect the Reverse Stock Split authorized by stockholders, in its sole discretion. Votes For Votes Against Abstentions Broker Non-Votes 36,030,837 2,418,669 450,037 —